Leadership Team
Philip Chase
Chief Executive Officer- General Counsel, Alnylam Pharmaceuticals
- General Counsel, Epix Pharmaceuticals
- Chief Corporate Counsel, Transkaryotic Therapies (TKT)
Eric Krauland, PhD
President and Chief Scientific OfficerRyan McGovern
Chief Financial OfficerGuy Van Meter
Chief Business Officer- Business Development and Strategic Alliances, Pfizer
- Business Development, Technology Licensing, Dyax
- F.W. Olin Graduate School of Management at Babson
Max Vásquez, PhD
Chief Computing Officer- Senior Director, Research, PDL BioPharma
- Bocaraca Consulting, Founder and President
Senior Directors
Amy Bray
Senior Director, Legal- Associate, Sterne, Kessler, Goldstein & Fox
- Associate, LeClair Ryan
- Law Clerk, Hunton & Williams
- UT Southwestern Medical Center
Kirt Johnson
Senior Director, Product Engineering & Operations- Director of Product Development, NextMark
- Technology Development Director, King Arthur Flour Company
- Director, Systems Architecture and Senior Architect, Applications, Affinity Internet
Juergen Nett, PhD
Senior Director, High-Throughput Expression- Senior Principal Scientist, Merck
- Senior Scientist, GlycoFi
- Dartmouth Medical School
- University of Kaiserslautern
Robert Pejchal, PhD
Vice President, Antibody EngineeringKristin Rookey
Vice President, Strategic AlliancesKaty Seneca
Senior Director, Finance & Accounting- Aldrich Advisors (formerly Aldrich Kilbride & Tatone)
- Gallagher, Flynn, & Company
- Saint Michael’s College
Marianne Thomson
Vice President, Human Resources- Georgetown University
- American University
- Syracuse University
- Dartmouth College
Paul Widboom
Senior Director, Antibody EngineeringFounders
Tillman U. Gerngross, PhD
Co-Founder and Executive Chairman of the Board- Professor of Bioengineering, Dartmouth College
- Co-Founder and CSO, GlycoFi (acquired by Merck 2006)
- Venture Partner, SV Health Investors
- Co-Founder, Chairman of Arsanis (merged with NASDAQ:XFOR in 2019)
- Co-Founder, Chairman of Avitide
- Co-Founder, Chairman of Alector (NASDAQ: ALEC)
- Co-Founder, President, Amagma Therapeutics, Waltham, MA
- Co-Founder, President, Ankyra Therapeutics, Boston, MA
- Co-Founder, Adagio Therapeutics, Waltham, MA
K. Dane Wittrup, PhD
Co-Founder and Chairman of the SAB- Co-Founder, BioDisplay Technologies (acquired by Abbott Laboratories 2001)
- Professor of Chemical Engineering and Bioengineering, Massachusetts Institute of Technology
- Co-Founder of Eleven Biotherapeutics